Full metadata record
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technologyen_US
dc.contributor.advisorKo, Chi Bun Ben (ABCT)en_US
dc.creatorWang, Yixiang-
dc.identifier.urihttps://theses.lib.polyu.edu.hk/handle/200/13996-
dc.languageEnglishen_US
dc.publisherHong Kong Polytechnic Universityen_US
dc.rightsAll rights reserveden_US
dc.titleFunctional role of CBX2 in the pathogenesis of hepatocellular carcinomaen_US
dcterms.abstractChromobox 2 (CBX2) is an essential component of the canonical Polycomb Repressive Complex 1 (cPRC1), which plays a role in epigenetic regulation and gene silencing. Earlier findings suggested that aberrant expression of CBX2 is associated with poor prognosis in hepatocellular carcinoma (HCC). However, the underlying mechanisms remain elusive. We confirmed that CBX2 is overexpressed in a subpopulation of HCC patients. While CBX2 expression is low in non-tumorous liver cell lines, it is overexpressed to varying levels in most HCC cell lines examined. CBX2-overexpressing and -knockout cell models were generated to determine the functions of CBX2 in HCC pathogenesis. We found that growth and migratory ability of HCC cells are directly correlated with CBX2 expression levels. Gene knockout of CBX2 also profoundly reduced HCC tumor growth in vivo. Transcriptomic and bioinformatics analyses further suggested that genes of the metabolic pathways are enriched in the CBX2-knockout cells. Concordantly, cell growth inhibition of CBX2 knockout cells were associated with reduction in rate of glycolysis and oxidative phosphorylation, with a concomitant reduction in ATP and NAD+ level. Bioinformatics analysis and functional screen led to the identification of phosphoenolpyruvate carboxykinase 2 (PCK2), a mitochondrial enzyme that catalyzes the conversion of oxaloacetate to phosphoenolpyruvate in the gluconeogenic pathway, was induced in CBX2 knockdown cells and responsible for the growth-inhibition found in these cells. Importantly, knockdown of PCK2 in CBX2-knockout cells restored the rate of glycolysis and NAD+ level, and completely rescued the cell growth defects due to CBX2 deficiency. Interestingly, overexpression of PCK1, the cytosolic from of PCK, did not have any effect on CBX2-knockout cells. Together these data suggested that PCK2 potentially regulates cell growth through yet-unknown activity. Our findings uncovered a novel functional role of CBX2-PCK2 regulatory axis in HCC growth, revealed a novel target for the development of novel HCC therapeutics.en_US
dcterms.extent102 pages : color illustrationsen_US
dcterms.isPartOfPolyU Electronic Thesesen_US
dcterms.issued2025en_US
dcterms.educationalLevelPh.D.en_US
dcterms.educationalLevelAll Doctorateen_US
dcterms.accessRightsopen accessen_US

Files in This Item:
File Description SizeFormat 
8457.pdfFor All Users4.24 MBAdobe PDFView/Open


Copyright Undertaking

As a bona fide Library user, I declare that:

  1. I will abide by the rules and legal ordinances governing copyright regarding the use of the Database.
  2. I will use the Database for the purpose of my research or private study only and not for circulation or further reproduction or any other purpose.
  3. I agree to indemnify and hold the University harmless from and against any loss, damage, cost, liability or expenses arising from copyright infringement or unauthorized usage.

By downloading any item(s) listed above, you acknowledge that you have read and understood the copyright undertaking as stated above, and agree to be bound by all of its terms.

Show simple item record

Please use this identifier to cite or link to this item: https://theses.lib.polyu.edu.hk/handle/200/13996